Graham H. Jackson

Common variation at 3p22.1 and 7p15.3 influences multiple myeloma risk

Thomas W. Mühleisen, T. Mühleisen, M. Nöthen, 2011, Nature Genetics.

LYMPHOID NEOPLASIA Coexistent hyperdiploidy does not abrogate poor prognosis in myeloma with adverse cytogenetics and may precede IGH translocations

W. Gregory, M. Drayson, C. Wardell, 2015 .

Serum free immunoglobulin light chain evaluation as a marker of impact from intraclonal heterogeneity on myeloma outcome.

W. Gregory, M. Drayson, M. Cavo, 2014, Blood.

The role of maintenance thalidomide therapy in multiple myeloma: MRC Myeloma IX results and meta-analysis.

G. Morgan, W. Gregory, M. Drayson, 2012, Blood.